Volume 67, Issue 2, Pages (August 2017)

Slides:

Advertisements

Similar presentations

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep

Advertisements

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.

Global gene repression in hepatocellular carcinoma and fetal liver, and suppression of dudulin-2 mRNA as a possible marker for the cirrhosis-to-tumor transition.

Volume 61, Issue 1, Pages (July 2014)

Volume 63, Issue 1, Pages (July 2015)

Volume 46, Issue 3, Pages (March 2007)

Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen

Inflammasomes in liver diseases

Volume 61, Issue 4, Pages (October 2014)

Volume 50, Issue 4, Pages (April 2009)

MELD: the holy grail of organ allocation?

Global trends and predictions in hepatocellular carcinoma mortality

Volume 68, Issue 5, Pages (May 2018)

Impact of PNPLA3 variants on liver histology of 168 patients with HIV infection and chronic hepatitis C C. Sagnelli, M. Merli, C. Uberti-Foppa, H. Hasson,

Volume 61, Issue 6, Pages (December 2014)

Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar

Reactive oxygen species in the normal and acutely injured liver

Matthew T. Kitson, Stuart K. Roberts Journal of Hepatology

NS5A inhibitors in the treatment of hepatitis C

Immigration and viral hepatitis

Individualized prediction of hepatocellular carcinoma occurrence in a large cohort of patients with cirrhosis Astrid Marot, Jean Henrion, Jean-François.

Volume 66, Issue 1, Pages 1-4 (January 2017)

Living donor liver transplantation: is the hype over?

Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection Anaïs Vallet-Pichard,

The place of downstaging for hepatocellular carcinoma

Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw Journal of Hepatology

Volume 65, Issue 4, Pages (October 2016)

European Association for the Study of the Liver Journal of Hepatology

Volume 68, Issue 1, Pages (January 2018)

Familial amyloid polyneuropathy and liver transplantation

Hepatitis C core protein – The “core” of immune deception?

Volume 61, Issue 1, Pages S108-S119 (November 2014)

Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel

Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study Gyuri Kim, Suk-Yong Jang, Chung.

Volume 61, Issue 1, Pages S69-S78 (November 2014)

Why men are at higher risk for hepatocellular carcinoma?

Volume 62, Issue 3, Pages (March 2015)

Genomic risk of hepatitis C-related hepatocellular carcinoma

Darius Moradpour, Arash Grakoui, Michael P. Manns

Autophagy in the liver Journal of Hepatology

EASL Clinical Practice Guidelines: Wilson’s disease

Roberto de Franchis, Aleksander Krag Journal of Hepatology

Volume 61, Issue 1, Pages S45-S57 (November 2014)

Volume 65, Issue 2, Pages (August 2016)

Volume 57, Issue 5, Pages (November 2012)

Volume 50, Issue 4, Pages (April 2009)

Non-invasive diagnosis and biomarkers in alcohol-related liver disease

Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong

Volume 52, Issue 5, Pages (May 2010)

Paul C. Adams, James C. Barton Journal of Hepatology

Chetana Lim, Chady Salloum, Daniel Azoulay

Immigration and viral hepatitis

Evolution of liver transplantation for hepatocellular carcinoma

Role of desmoplasia in cholangiocarcinoma and hepatocellular carcinoma

Volume 63, Issue 1, Pages (July 2015)

Volume 51, Issue 2, Pages (August 2009)

Hepatitis C infection: A multi-faceted systemic disease with clinical, patient reported and economic consequences Zobair M. Younossi, Aybike Birerdinc,

Volume 66, Issue 3, Pages (March 2017)

Volume 49, Issue 1, Pages (July 2008)

Integrating sorafenib into an algorithm for the management of post-transplant hepatocellular carcinoma recurrence Christian Toso, Gilles Mentha, Pietro.

Vincenzo Mazzaferro, Andrea Pulvirenti, Jorgelina Coppa

New trials and results in systemic treatment of HCC

Liver transplantation in children

Reply to: “Flow cytometry makes all the difference”

Pathogenesis of cholestatic hepatitis C

Chimeric mouse model of hepatitis B virus infection

The relationship between age and fat infiltration in liver and muscle

Genetics of hepatocellular carcinoma: The next generation

MELD: the holy grail of organ allocation?

Reversion of disease manifestations after HCV eradication

Presentation transcript:

Volume 67, Issue 2, Pages 415-417 (August 2017) Occurrence of hepatocellular carcinoma in HIV/HCV co-infected patients treated with direct-acting antivirals Hamid Hasson, Marco Merli, Emanuela Messina, Sherrie Bhoori, Stefania Salpietro, Giulia Morsica, Enrico Regalia, Sabrina Bagaglio, Adriano Lazzarin, Caterina Uberti-Foppa, Vincenzo Mazzaferro Journal of Hepatology Volume 67, Issue 2, Pages 415-417 (August 2017) DOI: 10.1016/j.jhep.2017.03.032 Copyright © 2017 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Survival curves for cumulative incidence of HCC in all patients and in those infected by genotype 3. Journal of Hepatology 2017 67, 415-417DOI: (10.1016/j.jhep.2017.03.032) Copyright © 2017 European Association for the Study of the Liver Terms and Conditions